The global continuous blood glucose monitoring market reached a value of nearly $5,684.5 million in 2021, having grown at a compound annual growth rate (CAGR) of 19.7% since 2016. The market is expected to grow from $5,684.5 million in 2021 to $12,726.6 million in 2026 at a rate of 17.5%. The market is then expected to grow at a CAGR of 19.5% from 2026 and reach $31,050.3 million in 2031.
Growth in the historic period resulted from increasing obesity, emerging markets growth, rapid urbanization, increased healthcare expenditure and increased geriatric population. Factors that negatively affected growth in the historic period were low healthcare access, regulatory challenges and lack of awareness about diabetes and continuous glucose monitoring systems.
Going forward, increased incidence of diabetes, increasing use of continuous blood glucose monitoring systems, increasing government initiatives and an increase in chronic diseases will drive the growth. Factors that could hinder the growth of the continuous blood glucose monitoring market in the future include high cost and a rise in interest rates.
The continuous blood glucose monitoring market is segmented by components into insulin pumps, sensors, transmitters, and receivers. The sensors market was the largest segment of the continuous blood glucose monitoring market segmented by components, accounting for 50.6% of the total in 2021. Going forward, the sensors segment is expected to be the fastest growing segment in the continuous blood glucose monitoring market segmented by components, at a CAGR of 18.10% during 2021-2026.
The continuous blood glucose monitoring market is segmented by application into type 1 diabetic patients, type 2 diabetic patients, gestational diabetes and critical care patients. The type 2 diabetic patients market was the largest segment of the continuous blood glucose monitoring market segmented by application, accounting for 85.3% of the total in 2021. Going forward, the type 2 diabetic patients segment is expected to be the fastest growing segment in the continuous blood glucose monitoring market segmented by application, at a CAGR of 17.7% during 2021-2026.
The continuous blood glucose monitoring market is segmented by end user into hospitals, homecare diagnostics and other end users. The homecare diagnostics market was the largest segment of the continuous blood glucose monitoring market segmented by end user, accounting for 50.0% of the total in 2021. Going forward, the homecare diagnostics segment is expected to be the fastest growing segment in the continuous blood glucose monitoring market segmented by end user, at a CAGR of 18.1% during 2021-2026.
North America was the largest region in the continuous blood glucose monitoring market, accounting for 42.3% of the total in 2021. It was followed by Asia Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the continuous blood glucose monitoring market will be North America and Western Europe where growth will be at CAGRs of 19.3% and 17.8% respectively. These will be followed by Asia Pacific and South America where the markets are expected to grow at CAGRs of 15.9% and 15.4% respectively.
The global continuous blood glucose monitoring market is concentrated, with a few large players. The top ten competitors in the market made up to 93.30% of the total market in 2021. This can be due to the existence of number of local players in the market serving customers in particular geographies. Technological innovations in the recent past helped the companies to strengthen their market presence. Abbott Laboratories Holdings, Inc. was the largest competitor with 41.66% share of the market, followed by Dexcom, Inc. with 38.77%, Medtronic plc with 12.34%, Senseonics Holdings, Inc. with 0.24%, A. Menarini Diagnostics with 0.19%, Medtrum Technologies, Inc. with 0.04%, SB Solutions with 0.02%, DiaMonTech AG with 0.02%, Nemaura Medical Inc. with 0.01%, and Metronom Health with 0.01%. The other players are Veri, Zhejiang POCTech Co.,Ltd., WaveForm Diabetes (revenue is not available for these through secondary) and other players.
The top opportunities in the continuous blood glucose monitoring market segmented by components will arise in the sensors segment, which will gain $3,734.2 million of global annual sales by 2026. The top opportunities in the continuous blood glucose monitoring market segmented by application will arise in the type 2 diabetic patients segment, which will gain $6,124.0 million of global annual sales by 2026. The top opportunities in the continuous blood glucose monitoring market segmented by end user will arise in the homecare diagnostics segment, which will gain $3,690.0 million of global annual sales by 2026. The continuous blood glucose monitoring market size will gain the most in USA at $2,473.8 million.
Market-trend-based strategies for the continuous blood glucose monitoring market include new product launches, new technology development and new investments in business.
Player-adopted strategies in the continuous blood glucose monitoring market include focus on launching new products with advanced features and in different geographic areas and strengthening product portfolio by forming partnerships with companies having same business to commercialize products.
To take advantage of the opportunities, the publisher recommends the companies in the continuous blood glucose monitoring market to focus on use of artificial intelligence in continuous blood glucose monitoring, focus on new product launches, focus on technology advancements, expand in emerging markets, continue to focus on developed markets, focus on partnerships and collaborations, provide competitively priced offerings, participate in trade shows and events, continue to use business-to-business (B2B) promotions, continue to target fast-growing end-users and focus on fast-growing applications.
This report describes and explains the continuous blood glucose monitoring market and covers 2016-2021, termed the historic period, and 2021-2026 termed the forecast period, along with further forecasts for the period 2026-2031. The report evaluates the market across each region and for the major economies within each region.
Growth in the historic period resulted from increasing obesity, emerging markets growth, rapid urbanization, increased healthcare expenditure and increased geriatric population. Factors that negatively affected growth in the historic period were low healthcare access, regulatory challenges and lack of awareness about diabetes and continuous glucose monitoring systems.
Going forward, increased incidence of diabetes, increasing use of continuous blood glucose monitoring systems, increasing government initiatives and an increase in chronic diseases will drive the growth. Factors that could hinder the growth of the continuous blood glucose monitoring market in the future include high cost and a rise in interest rates.
The continuous blood glucose monitoring market is segmented by components into insulin pumps, sensors, transmitters, and receivers. The sensors market was the largest segment of the continuous blood glucose monitoring market segmented by components, accounting for 50.6% of the total in 2021. Going forward, the sensors segment is expected to be the fastest growing segment in the continuous blood glucose monitoring market segmented by components, at a CAGR of 18.10% during 2021-2026.
The continuous blood glucose monitoring market is segmented by application into type 1 diabetic patients, type 2 diabetic patients, gestational diabetes and critical care patients. The type 2 diabetic patients market was the largest segment of the continuous blood glucose monitoring market segmented by application, accounting for 85.3% of the total in 2021. Going forward, the type 2 diabetic patients segment is expected to be the fastest growing segment in the continuous blood glucose monitoring market segmented by application, at a CAGR of 17.7% during 2021-2026.
The continuous blood glucose monitoring market is segmented by end user into hospitals, homecare diagnostics and other end users. The homecare diagnostics market was the largest segment of the continuous blood glucose monitoring market segmented by end user, accounting for 50.0% of the total in 2021. Going forward, the homecare diagnostics segment is expected to be the fastest growing segment in the continuous blood glucose monitoring market segmented by end user, at a CAGR of 18.1% during 2021-2026.
North America was the largest region in the continuous blood glucose monitoring market, accounting for 42.3% of the total in 2021. It was followed by Asia Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the continuous blood glucose monitoring market will be North America and Western Europe where growth will be at CAGRs of 19.3% and 17.8% respectively. These will be followed by Asia Pacific and South America where the markets are expected to grow at CAGRs of 15.9% and 15.4% respectively.
The global continuous blood glucose monitoring market is concentrated, with a few large players. The top ten competitors in the market made up to 93.30% of the total market in 2021. This can be due to the existence of number of local players in the market serving customers in particular geographies. Technological innovations in the recent past helped the companies to strengthen their market presence. Abbott Laboratories Holdings, Inc. was the largest competitor with 41.66% share of the market, followed by Dexcom, Inc. with 38.77%, Medtronic plc with 12.34%, Senseonics Holdings, Inc. with 0.24%, A. Menarini Diagnostics with 0.19%, Medtrum Technologies, Inc. with 0.04%, SB Solutions with 0.02%, DiaMonTech AG with 0.02%, Nemaura Medical Inc. with 0.01%, and Metronom Health with 0.01%. The other players are Veri, Zhejiang POCTech Co.,Ltd., WaveForm Diabetes (revenue is not available for these through secondary) and other players.
The top opportunities in the continuous blood glucose monitoring market segmented by components will arise in the sensors segment, which will gain $3,734.2 million of global annual sales by 2026. The top opportunities in the continuous blood glucose monitoring market segmented by application will arise in the type 2 diabetic patients segment, which will gain $6,124.0 million of global annual sales by 2026. The top opportunities in the continuous blood glucose monitoring market segmented by end user will arise in the homecare diagnostics segment, which will gain $3,690.0 million of global annual sales by 2026. The continuous blood glucose monitoring market size will gain the most in USA at $2,473.8 million.
Market-trend-based strategies for the continuous blood glucose monitoring market include new product launches, new technology development and new investments in business.
Player-adopted strategies in the continuous blood glucose monitoring market include focus on launching new products with advanced features and in different geographic areas and strengthening product portfolio by forming partnerships with companies having same business to commercialize products.
To take advantage of the opportunities, the publisher recommends the companies in the continuous blood glucose monitoring market to focus on use of artificial intelligence in continuous blood glucose monitoring, focus on new product launches, focus on technology advancements, expand in emerging markets, continue to focus on developed markets, focus on partnerships and collaborations, provide competitively priced offerings, participate in trade shows and events, continue to use business-to-business (B2B) promotions, continue to target fast-growing end-users and focus on fast-growing applications.
This report describes and explains the continuous blood glucose monitoring market and covers 2016-2021, termed the historic period, and 2021-2026 termed the forecast period, along with further forecasts for the period 2026-2031. The report evaluates the market across each region and for the major economies within each region.
Table of Contents
1. Executive Summary2. Table of Contents
3. List of Figures
4. List of Tables
5. Report Structure
6. Introduction and Market Characteristics
6.1. General Market Definition
6.2. Summary
6.3. Continuous Blood Glucose Monitoring Market Definition and Segmentations
6.4. Market Segmentation By Components
6.4.1. Insulin Pumps
6.4.2. Sensors
6.4.3. Transmitters
6.4.4. Receivers
6.5. Market Segmentation By Application
6.5.1. Type 1 Diabetic Patients
6.5.2. Type 2 Diabetic Patients
6.5.3. Gestational Diabetes
6.5.4. Critical Care Patients
6.6. Market Segmentation By End User
6.6.1. Hospitals
6.6.2. Homecare Diagnostics
6.6.3. Other End Users
7. Major Market Trends
7.1. New Product Launches
7.2. New Technology Development
7.3. Increasing Investments
8. Global Market Size And Growth
8.1. Market Size
8.2. Historic Market Growth, 2016 - 2021, Value ($ Million)
8.2.1. Market Drivers 2016 - 2021
8.2.2. Market Restraints 2016 - 2021
8.3. Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
8.3.1. Market Drivers 2021 - 2026
8.3.2. Market Restraints 2021 - 2026
9. Global Market Segmentation
9.1. Global Continuous Blood Glucose Monitoring Market, Segmentation By Components, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
9.2. Global Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
9.3. Global Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
10. Global Market, Regional And Country Analysis
10.1. Global Continuous Blood Glucose Monitoring Market, By Region, Historic and Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
10.2. Global Continuous Blood Glucose Monitoring Market, By Country, Historic and Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11. Asia-Pacific Market
11.1. Summary
11.2. Market Overview
11.2.1. Region Information
11.2.2. Market Information
11.2.3. Background Information
11.2.4. Government Initiatives
11.2.5. Regulations
11.2.6. Regulatory Bodies
11.2.7. Major Associations
11.2.8. Taxes Levied
11.2.9. Corporate Tax Structure
11.2.10. Investments
11.2.11. Major Companies
11.3. Asia-Pacific Continuous Blood Glucose Monitoring Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.4. Asia-Pacific Continuous Blood Glucose Monitoring Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.5. Asia-Pacific Continuous Blood Glucose Monitoring Market, Segmentation By Components, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.6. Asia-Pacific Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.7. Asia-Pacific Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.8. Asia Pacific Continuous Blood Glucose Monitoring Market: Country Analysis
11.9. China Market
11.10. Summary
11.11. Market Overview
11.11.1. Country Information
11.11.2. Market Information
11.11.3. Background Information
11.11.4. Government Initiatives
11.11.5. Regulations
11.11.6. Regulatory Bodies
11.11.7. Major Associations
11.11.8. Taxes Levied
11.11.9. Corporate Tax Structure
11.11.10. Investments
11.11.11. Major Companies
11.12. China Continuous Blood Glucose Monitoring Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.13. China Continuous Blood Glucose Monitoring Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.14. China Continuous Blood Glucose Monitoring Market, Segmentation By Components, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.15. China Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.16. China Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.17. India Market
11.18. India Continuous Blood Glucose Monitoring Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.19. India Continuous Blood Glucose Monitoring Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.20. India Continuous Blood Glucose Monitoring Market, Segmentation By Components, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.21. India Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.22. India Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.23. Japan Market
11.24. Japan Continuous Blood Glucose Monitoring Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.25. Japan Continuous Blood Glucose Monitoring Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.26. Japan Continuous Blood Glucose Monitoring Market, Segmentation By Components, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.27. Japan Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.28. Japan Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.29. Australia Market
11.30. Australia Continuous Blood Glucose Monitoring Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.31. Australia Continuous Blood Glucose Monitoring Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.32. Australia Continuous Blood Glucose Monitoring Market, Segmentation By Components, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.33. Australia Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.34. Australia Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.35. Indonesia Market
11.36. Indonesia Continuous Blood Glucose Monitoring Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.37. Indonesia Continuous Blood Glucose Monitoring Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.38. Indonesia Continuous Blood Glucose Monitoring Market, Segmentation By Components, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.39. Indonesia Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.40. Indonesia Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.41. South Korea Market
11.42. South Korea Continuous Blood Glucose Monitoring Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.43. South Korea Continuous Blood Glucose Monitoring Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.44. South Korea Continuous Blood Glucose Monitoring Market, Segmentation By Components, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.45. South Korea Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.46. South Korea Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12. Western Europe Market
12.1. Summary
12.2. Market Overview
12.2.1. Region Information
12.2.2. Market Information
12.2.3. Background Information
12.2.4. Government Initiatives
12.2.5. Regulatory bodies
12.2.6. Major Associations
12.2.7. Taxes Levied
12.2.8. Corporate Tax Structure
12.2.9. Investments
12.2.10. Major Companies
12.3. Western Europe Continuous Blood Glucose Monitoring Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
12.4. Western Europe Continuous Blood Glucose Monitoring Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
12.5. Western Europe Continuous Blood Glucose Monitoring Market, Segmentation By Components, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.6. Western Europe Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.7. Western Europe Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.8. Western Europe Continuous Blood Glucose Monitoring Market: Country Analysis
12.9. UK Market
12.10. UK Continuous Blood Glucose Monitoring Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
12.11. UK Continuous Blood Glucose Monitoring Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
12.12. UK Continuous Blood Glucose Monitoring Market, Segmentation By Components, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.13. UK Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.14. UK Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.15. Germany Market
12.16. Germany Continuous Blood Glucose Monitoring Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
12.17. Germany Continuous Blood Glucose Monitoring Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
12.18. Germany Continuous Blood Glucose Monitoring Market, Segmentation By Components, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.19. Germany Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.20. Germany Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.21. France Market
12.22. France Continuous Blood Glucose Monitoring Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
12.23. France Continuous Blood Glucose Monitoring Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
12.24. France Continuous Blood Glucose Monitoring Market, Segmentation By Components, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.25. France Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.26. France Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13. Eastern Europe Market
13.1. Summary
13.2. Market Overview
13.2.1. Region Information
13.2.2. Market Information
13.2.3. Background Information
13.2.4. Government Initiatives
13.2.5. Regulations
13.2.6. Regulatory Bodies
13.2.7. Major Associations
13.2.8. Taxes Levied
13.2.9. Corporate Tax Structure
13.2.10. Investments
13.2.11. Major Companies
13.3. Eastern Europe Continuous Blood Glucose Monitoring Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
13.4. Eastern Europe Continuous Blood Glucose Monitoring Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
13.5. Eastern Europe Continuous Blood Glucose Monitoring Market, Segmentation By Components, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.6. Eastern Europe Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.7. Eastern Europe Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.8. Eastern Europe Continuous Blood Glucose Monitoring Market: Country Analysis
13.9. Russia Market
13.10. Russia Continuous Blood Glucose Monitoring Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
13.11. Russia Continuous Blood Glucose Monitoring Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
13.12. Russia Continuous Blood Glucose Monitoring Market, Segmentation By Components, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.13. Russia Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.14. Russia Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14. North America Market
14.1. Summary
14.2. Market Overview
14.2.1. Region Information
14.2.2. Market Information
14.2.3. Background Information
14.2.4. Government Initiatives
14.2.5. Regulations
14.2.6. Regulatory Body
14.2.7. Major Associations
14.2.8. Taxes levied
14.2.9. Corporate Tax Structure
14.2.10. Investments
14.2.11. Major Companies
14.3. North America Continuous Blood Glucose Monitoring Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
14.4. North America Continuous Blood Glucose Monitoring Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
14.5. North America Continuous Blood Glucose Monitoring Market, Segmentation By Components, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.6. North America Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.7. North America Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.8. North America Continuous Blood Glucose Monitoring Market: Country Analysis
14.9. USA Market
14.10. Summary
14.11. Market Overview
14.11.1. Country Information
14.11.2. Market Information
14.11.3. Background Information
14.11.4. Government Initiatives
14.11.5. Regulations
14.11.6. Regulatory Bodies
14.11.7. Major Associations
14.11.8. Taxes Levied
14.11.9. Corporate Tax Structure
14.11.10. Investments
14.11.11. Major Companies
14.12. USA Continuous Blood Glucose Monitoring Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
14.13. USA Continuous Blood Glucose Monitoring Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
14.14. USA Continuous Blood Glucose Monitoring Market, Segmentation By Components, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.15. USA Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.16. USA Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15. South America Market
15.1. Summary
15.2. Market Overview
15.2.1. Region Information
15.2.2. Market Information
15.2.3. Background Information
15.2.4. Government Initiatives
15.2.5. Regulations
15.2.6. Regulatory Bodies
15.2.7. Major Associations
15.2.8. Taxes Levied
15.2.9. Corporate Tax Structure
15.2.10. Investments
15.2.11. Major Companies
15.3. South America Continuous Blood Glucose Monitoring Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
15.4. South America Continuous Blood Glucose Monitoring Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
15.5. South America Continuous Blood Glucose Monitoring Market, Segmentation By Components, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.6. South America Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.7. South America Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.8. South America Continuous Blood Glucose Monitoring Market: Country Analysis
15.9. Brazil Market
15.10. Brazil Continuous Blood Glucose Monitoring Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
15.11. Brazil Continuous Blood Glucose Monitoring Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
15.12. Brazil Continuous Blood Glucose Monitoring Market, Segmentation By Components, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.13. Brazil Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.14. Brazil Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
16. Middle East Market
16.1. Summary
16.2. Market Overview
16.2.1. Region Information
16.2.2. Market Information
16.2.3. Background Information
16.2.4. Government Initiatives
16.2.5. Regulations
16.2.6. Regulatory Bodies
16.2.7. Major Associations
16.2.8. Taxes Levied
16.2.9. Corporate Tax Structure
16.2.10. Investments
16.2.11. Major Companies
16.3. Middle East Continuous Blood Glucose Monitoring Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
16.4. Middle East Continuous Blood Glucose Monitoring Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
16.5. Middle East Continuous Blood Glucose Monitoring Market, Segmentation By Components, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
16.6. Middle East Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
16.7. Middle East Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
17. Africa Market
17.1. Summary
17.2. Market Overview
17.2.1. Region Information
17.2.2. Market Information
17.2.3. Background Information
17.2.4. Government Initiatives
17.2.5. Regulations
17.2.6. Regulatory Bodies
17.2.7. Major Associations
17.2.8. Taxes Levied
17.2.9. Corporate Tax Structure
17.2.10. Major Companies
17.3. Africa Continuous Blood Glucose Monitoring Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
17.4. Africa Continuous Blood Glucose Monitoring Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
17.5. Africa Continuous Blood Glucose Monitoring Market, Segmentation By Components, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
17.6. Africa Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
17.7. Africa Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
18. Competitive Landscape And Company Profiles
18.1. Company Profiles
18.2. Abbott Laboratories
18.2.1. Company Overview
18.2.2. Products And Services
18.2.3. Business Strategy
18.2.4. Financial Overview
18.3. Dexcom, Inc.
18.3.1. Company Overview
18.3.2. Products And Services
18.3.3. Business Strategy
18.3.4. Financial Overview
18.4. Medtronic plc
18.4.1. Company Overview
18.4.2. Products And Services
18.4.3. Business Strategy
18.4.4. Financial Overview
18.5. Senseonics Holdings, Inc.
18.5.1. Company Overview
18.5.2. Products And Services
18.5.3. Business Strategy
18.5.4. Financial Overview
18.6. A. Menarini Diagnostics
18.6.1. Company Overview
18.6.2. Products And Services
18.6.3. Business Strategy
18.6.4. Financial Overview
18.7. New Companies Entering The Market
18.7.1. GlucoTrack, Inc.
18.7.2. LifeScan
18.7.3. Graphwear
18.7.4. Infinovo
18.7.5. GlucoRx
18.7.6. Integrated Medical Sensors
18.7.7. i-SENS
18.7.8. Pacific Diabetes Technologies
18.7.9. WaveForm Technologies
18.7.10. Ascensia
18.7.11. GluSense
18.7.12. GlySens
18.7.13. PercuSense
18.7.14. Biolinq
18.7.15. Indigo Diabetes
18.7.16. Echo Therapeutics
19. Key Mergers and Acquisitions
19.1. Glooko Acquired Xbird
19.2. Eli Lily And Company Acquired Promoter Technologies
19.3. Carbon Health Acquired Steady Health
19.4. Medtronic Acquired Companion Medical
19.5. One Drop Acquired Sano Intelligence Inc
20. Global Continuous Blood Glucose Monitoring Market Opportunities And Strategies
20.1. Global Continuous Blood Glucose Monitoring Market In 2026 - Countries Offering Most New Opportunities
20.2. Global Continuous Blood Glucose Monitoring Market In 2026 - Segments Offering Most New Opportunities
20.3. Global Continuous Blood Glucose Monitoring Market In 2026 - Growth Strategies
20.3.1. Market Trend Based Strategies
20.3.2. Competitor Strategies
21. Continuous Blood Glucose Monitoring Market, Conclusions And Recommendations
21.1. Conclusions
21.2. Recommendations
21.2.1. Product
21.2.2. Place
21.2.3. Price
21.2.4. Promotion
21.2.5. People
22. Appendix
22.1. Market Data Sources
22.2. Research Methodology
22.3. Currencies
22.4. About the Publisher
22.5. Copyright and Disclaimer
Executive Summary
Continous Blood Glucose Monitoring Global Market Opportunities And Strategies To 2031 provides the strategists; marketers and senior management with the critical information they need to assess the global continous blood glucose monitoring market as it emerges from the COVID-19 shut down.Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider continous blood glucose monitoring market; and compares it with other markets.
The report covers the following chapters:
- Introduction and Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the continous blood glucose monitoring market.
- Key Trends - Highlights the major trends shaping the global continous blood glucose monitoring market. This section also highlights likely future developments in the market.
- Global Market Size and Growth - Global historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
- Regional And Country Analysis - Historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values and growth and market share comparison by region.
- Market Segmentation - Contains the market values (2016-2031) and analysis for each segment by components, by application and by end user in the market.
- Regional Market Size and Growth - Regional market size (2021), historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values, and growth and market share comparison of countries within the region. This report includes information on the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, and major countries within each region.
- Competitive Landscape - Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
- Key Mergers and Acquisitions - Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
- Market Opportunities And Strategies - Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
- Conclusions And Recommendations - Includes recommendations for continous blood glucose monitoring providers in terms of product/service offerings, geographic expansion, marketing strategies and target groups.
- Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Scope
Markets Covered
1) By Components: Insulin Pumps; Sensors; Transmitters; Receivers2) By Application: Type 1 Diabetic Patients; Type 2 Diabetic Patients; Gestational Diabetes; Critical Care Patients
3) By Application: Hospitals; Homecare Diagnostics; Other End Users
Companies Mentioned: Abbott Laboratories; Dexcom, Inc.; Medtronic plc; Senseonics Holdings, Inc.; A. Menarini Diagnostics
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time-series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; continous blood glucose monitoring indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Dexcom, Inc.
- Medtronic plc
- Senseonics Holdings, Inc.
- A. Menarini Diagnostics
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 299 |
| Published | January 2023 |
| Forecast Period | 2021 - 2031 |
| Estimated Market Value ( USD | $ 5684.5 Million |
| Forecasted Market Value ( USD | $ 31050.3 Million |
| Compound Annual Growth Rate | 18.5% |
| Regions Covered | Global |
